Clinical Trials Directory

Trials / Conditions / Infectious Mononucleosis

Infectious Mononucleosis

11 registered clinical trials studyying Infectious Mononucleosis — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingEpstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Ad
NCT06908096
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
Active Not RecruitingTrial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vacc
NCT05683834
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1 / Phase 2
Active Not RecruitingSafety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults
NCT04645147
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
WithdrawnA Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)
NCT04138875
Yale UniversityPhase 2
UnknownHIV Indicator Diseases in Hospital and Primary Care
NCT05225493
Erasmus Medical Center—
UnknownMicrobiology of Severe Acute Tonsillitis, Peritonsillar Cellulitis, and Infectious Mononucleosis
NCT02715037
Tejs Ehlers Klug—
TerminatedThe Use of Point-of-Care Ultrasound in the Diagnosis of Acute Infectious Mononucleosis in the Emergency Depart
NCT02463669
Jewish General Hospital—
CompletedStudy on Infectious Mononucleosis in Munich
NCT06002802
Technical University of Munich—
TerminatedAcupuncture for Infectious Mononucleosis Trial
NCT00598988
University of AlbertaPhase 2 / Phase 3
CompletedActivity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection
NCT00575185
University of MinnesotaPhase 1 / Phase 2
CompletedControlled Trial of Valacyclovir in Infectious Mononucleosis
NCT00274404
University of MinnesotaPhase 1 / Phase 2